DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo

4.51 0.45 (11.08%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

OREX $4.51 11.08%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.16
Previous Close $4.06
Daily Range $4.16 - $4.95
52-Week Range $3.11 - $7.82
Market Cap $552.6M
P/E Ratio -4.95
Dividend (Yield) $0.00 (0.0%)
Volume 8,773,013
Average Daily Volume 5,155,546
Current FY EPS -$0.46





Orexigen Therapeutics, Inc. (OREX) Description

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity. Website:

News & Commentary

3 Biotech Stocks Near 52-Week Lows Worth Buying

These may be cheap biotech stocks, but they may not be cheap for long according to the three analysts we asked.

Orexigen Launches Contrave - Watch For Traction

Merrill Lynch’s 5 Destroyed Biotech Stocks With 100% or More Upside Potential

Are People Too Concerned About Orexigen's Contrave Label?

Belviq Sales Dip: What To Watch For Ahead

Orexigen Up on $100M Milestone Payment from Takeda - Analyst Blog

What To Watch For As Orexigen's Launch Approaches

Shire PLC Takes A Dive As AbbVie Reconsiders Offer

Belviq Sales Rise Almost 5% Week Over Week

Stocks Hitting 52-Week Lows

See More OREX News...

OREX's Top Competitors

OREX $4.51 (11.08%)
Current stock: OREX
AMGN $144.09 (4.79%)
Current stock: AMGN
GILD $106.67 (4.36%)
Current stock: GILD
BIIB $326.77 (4.93%)
Current stock: BIIB